Soraya Ramoul is Director for global health partnerships at Novo Nordisk. She drives the Novo Nordisk strategy for access to health care and related programmes. Through the Changing Diabetes in Children programme Novo Nordisk provides care for 14,000 children in developing countries and through ‘The Access to Insulin Commitment’, the company guarantees low priced insulin for low income countries and humanitarian organisations. She joined Novo Nordisk in 2001. She has previous to her current position been Senior Advisor on Corporate Responsibility, where she was amongst others responsible for the company’s human rights programme. Prior to her time in Novo Nordisk Soraya Ramoul worked as legal advisor for various global businesses on human rights and business. Soraya Ramoul holds a Post Masters’ Degree in International Law from France.